Widely used:Recently Viewed
Clear All
Value Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹2,207 Cr
P/E Ratio
--
P/B Ratio
2.08
Industry P/E
54.87
Debt to Equity
0.59
ROE
9.09 %
ROCE
11.25 %
Div. Yield
0.63 %
Book Value
115.03
EPS
-2.72
CFO
₹1,279.16 Cr
EBITDA
₹1,884.07 Cr
Net Profit
₹791.29 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Indoco Remedies
| -27.79 | 9.64 | -26.38 | -27.91 | -14.76 | 0.70 | -4.15 |
|
BSE Healthcare
| -7.68 | 6.11 | -2.04 | 19.11 | 18.77 | 22.70 | 8.84 |
|
BSE Small Cap
| -12.49 | 9.35 | -8.34 | 5.55 | 17.55 | 35.38 | 15.06 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Indoco Remedies
| -14.88 | -2.82 | -10.49 | 49.29 | 61.26 | -12.11 | -24.03 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 315.95 | 3,444.94 | 65.42 | 24.79 | |
| 775.95 | 3,932.25 | 35.64 | 9.22 | |
| 2,201.80 | 3,634.04 | 45.92 | 23 | |
| 613.95 | 4,325.38 | -- | 4.09 |
Indoco Remedies Limited manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally. It offers stomatological, gastrointestinal, respiratory, anti-infective, vitamin/mineral/nutrient,... ophthal/ontological, antifungal, hormonal, dermatology, urological, anti-diabetic, gynaecological, lifestyle management, pain/analgesic, and cardiac products. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; anti-haemorrhoidals; antacids; antihistaminic; etc. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, heavy metal analysis, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, the company offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. Additionally, it provides contract research services, such as custom synthesis of molecules and intermediates, process chemistry research and development, non-infringing process designing and scale up, and analytical method development/validation solutions, as well as contract manufacturing services. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India. Read more
Incorporated
1947
Chairman
Suresh G Kare
Managing Director
Aditi Panandikar
Headquarters
Mumbai, Maharashtra
Website
Looking for more details about Indoco Remedies Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Indoco Remedies Ltd stood at ₹ 2,390 Cr as on 31-Dec-24
The share price of Indoco Remedies Ltd is ₹239.87 (NSE) and ₹239.25 (BSE) as of 17-Apr-2025 IST. Indoco Remedies Ltd has given a return of -14.76% in the last 3 years.
Indoco Remedies Ltd has a market capitalisation of ₹ 2,207 Cr as on 17-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Indoco Remedies Ltd is 2.08 times as on 17-Apr-2025, a 17% discount to its peers’ median range of 2.52 times.
Since, TTM earnings of Indoco Remedies Ltd is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Indoco Remedies Ltd and enter the required number of quantities and click on buy to purchase the shares of Indoco Remedies Ltd.
Indoco Remedies Limited manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally. It offers stomatological, gastrointestinal, respiratory, anti-infective, vitamin/mineral/nutrient, ophthal/ontological, antifungal, hormonal, dermatology, urological, anti-diabetic, gynaecological, lifestyle management, pain/analgesic, and cardiac products. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; anti-haemorrhoidals; antacids; antihistaminic; etc. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, heavy metal analysis, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, the company offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. Additionally, it provides contract research services, such as custom synthesis of molecules and intermediates, process chemistry research and development, non-infringing process designing and scale up, and analytical method development/validation solutions, as well as contract manufacturing services. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.
The prominent promoters of Indoco Remedies Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
SPA HOLDINGS PVT LTD |
19.88%
|
|
SHANTERI INVESTMENT PVT LTD |
17.19%
|
|
PANANDIKAR ADITI MILIND |
6.14%
|
|
MADHURA SURESH KARE |
5.68%
|
|
KARE ARUNA SURESH |
5.2%
|
The chairman of the company is Suresh G Kare, and the managing director is Aditi Panandikar.
There is no promoter pledging in Indoco Remedies Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
4,325
|
|
|
3,932
|
|
|
3,634
|
|
|
3,445
|
| Indoco Remedies Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
-2.28
|
|
Operating margin(%)
|
2.18
|
|
Net Margin(%)
|
-0.84
|
|
Dividend yield(%)
|
0.63
|
No, TTM profit after tax of Indoco Remedies Ltd was ₹-11 Cr.
₹0.09
(
